Interchange Capital Partners’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,753
| Closed | -$19.6K | – | 264 |
|
|
2024
Q2 | $19.6K | Buy |
4,753
+602
| +15% | +$2.48K | 0.01% | 262 |
|
|
2024
Q1 | $203K | Buy |
4,151
+980
| +31% | +$47.9K | 0.14% | 162 |
|
|
2023
Q4 | $215K | Buy |
3,171
+461
| +17% | +$31.2K | 0.16% | 139 |
|
|
2023
Q3 | $196K | Buy |
2,710
+333
| +14% | +$24.1K | 0.16% | 145 |
|
|
2023
Q2 | $177K | Buy |
2,377
+1,557
| +190% | +$116K | 0.13% | 146 |
|
|
2023
Q1 | $43.6K | Buy |
820
+179
| +28% | +$9.53K | 0.02% | 208 |
|
|
2022
Q4 | $43.3K | Sell |
641
-466
| -42% | -$31.5K | 0.04% | 125 |
|
|
2022
Q3 | $138K | Buy |
1,107
+34
| +3% | +$4.24K | 0.15% | 146 |
|
|
2022
Q2 | $102K | Buy |
1,073
+259
| +32% | +$24.6K | 0.11% | 151 |
|
|
2022
Q1 | $131K | Buy |
+814
| New | +$131K | 0.13% | 154 |
|